Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Study completedNCT00509665What this trial is testingGemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck CancerWho this might be right forHead and Neck Cancer Medical University of South Carolina 18
Testing effectiveness (Phase 2)Study completedNCT00230191What this trial is testingSafety and Efficacy of RK0202 in Oral MucositisWho this might be right forMouth DiseasesMouth UlcersOral Mucositis+1 more RxKinetix 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT04895735What this trial is testingMC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland CancerWho this might be right forMetastatic Salivary Gland CarcinomaRecurrent Salivary Gland CarcinomaStage IV Major Salivary Gland Cancer AJCC v8+1 more Mayo Clinic 45
Not applicableStudy completedNCT00896896What this trial is testingImmunoreactivity to Cetuximab in Cancer PatientsWho this might be right forColorectal CancerHead and Neck Cancer Vanderbilt-Ingram Cancer Center 538
Not applicableStudy completedNCT00828516What this trial is testingUsing Traditional Acupuncture in the Management of Cancer Treatment Related LymphoedemaWho this might be right forBreast CancerHead and Neck CancerLymphedema East and North Hertfordshire NHS Trust 56
Testing effectiveness (Phase 2)Study completedNCT00639769What this trial is testingIrinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer Vanderbilt-Ingram Cancer Center 41
Testing effectiveness (Phase 2)Looking for participantsNCT05884320What this trial is testingPhase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland CancersWho this might be right forGlandSalivary Gland Cancers M.D. Anderson Cancer Center 30
Not applicableLooking for participantsNCT00898638What this trial is testingTissue Sample Collection From Patients With Head and Neck Cancer and From Healthy ParticipantsWho this might be right forHead and Neck Cancer Vanderbilt University Medical Center 8,000
Testing effectiveness (Phase 2)Looking for participantsNCT04620187What this trial is testingPost-op T-DM1 in HER-2+ Salivary Gland CarcinomasWho this might be right forSalivary Gland CancerHER2 Gene Mutation Dana-Farber Cancer Institute 37
Early research (Phase 1)Study completedNCT00019110What this trial is testingVaccine Therapy in Treating Patients With Advanced or Recurrent CancerWho this might be right forAnal CancerCervical CancerEsophageal Cancer+3 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00024089What this trial is testingGefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00458978What this trial is testingCediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck CancerWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+20 more National Cancer Institute (NCI) 6
Not applicableStudy completedNCT03032250What this trial is testingPrepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck CancerWho this might be right forCaregiverMalignant Head and Neck NeoplasmParanasal Sinus Squamous Cell Carcinoma+35 more Wake Forest University Health Sciences 35
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT02538510What this trial is testingPembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by SurgeryWho this might be right forHead and Neck Squamous Cell CarcinomaRecurrent Nasal Cavity and Paranasal Sinus Squamous Cell CarcinomaRecurrent Nasopharynx Carcinoma+12 more University of Washington 50
Testing effectiveness (Phase 2)Study completedNCT00058006What this trial is testingCelecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung CancerWho this might be right forHead and Neck CancerLung Cancer Northwestern University
Large-scale testing (Phase 3)UnknownNCT01216800What this trial is testingIntensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid TumorsWho this might be right forHead and Neck CancerOtotoxicityRadiation Toxicity Institute of Cancer Research, United Kingdom 84
Testing effectiveness (Phase 2)UnknownNCT01762514What this trial is testingA Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine RegimensWho this might be right forNasopharyngeal NeoplasmsSalivary Gland DiseasesBone Marrow Diseases+1 more Sun Yat-sen University 360
Early research (Phase 1)Study completedNCT00031681What this trial is testing7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)Who this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more National Cancer Institute (NCI) 41